Warning: session_start(): open(/home/tayedi/public_html/src/var/sessions/sess_b7a403adfe109c33b00d97fd7fb01dca, O_RDWR) failed: No space left on device (28) in /home/tayedi/public_html/src/bootstrap.php on line 59

Warning: session_start(): Failed to read session data: files (path: /home/tayedi/public_html/src/var/sessions) in /home/tayedi/public_html/src/bootstrap.php on line 59
Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen. - Tayedi Search engine

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

1 hour ago 1

Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.

Read Entire Article

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

Related

A single crypto trader is sitting on a $194 million bet that...

Stablecoin market expands, bitcoin rallies as Iran war panic...

Traders snapped up nearly 600,000 BTC as bitcoin dipped belo...

Trending

Popular

More companies than usual are beating Wall Street’s expectat...

Binance teams up with Franklin Templeton to use tokenized mo...

Here are 7 charts guaranteed to stress you out about the sto...

Bitcoin remains in tight range under $70,000 ahead of Wednes...

LayerZero unveils ‘Zero’ chain, with Citadel, ARK backing

ETH open interest falls to 3-year low: What does it mean for...

Memory-chip stocks are still quite cheap — especially if you...

These ‘safer’ chip stocks have boomed this year. Is it too l...

Ledger adds OKX DEX integration for on-device token swaps

All social program benefits can be distributed onchain: Comp...